![Paroxetine HCl Hemihydrate EP Impurity A ; Paroxetine HCl Hemihydrate BP Impurity A ; Paroxetine HCl Anhydrous EP Impurity A ; Paroxetine HCl USP Related Compound B ; Desfluoro Paroxetine HCl ; (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine HCl | 324024-00-2 (base), 1322626-23-2 (HCl salt) ; 130777-05-8 (HCl salt) ;](http://drjcrbio.com/wp-content/themes/shopperpress/thumbs/p-171.png)
Paroxetine HCl Hemihydrate EP Impurity A ; Paroxetine HCl Hemihydrate BP Impurity A ; Paroxetine HCl Anhydrous EP Impurity A ; Paroxetine HCl USP Related Compound B ; Desfluoro Paroxetine HCl ; (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine HCl | 324024-00-2 (base), 1322626-23-2 (HCl salt) ; 130777-05-8 (HCl salt) ;
Paroxetine HCl Hemihydrate EP Impurity A
Description
| Code: JCPXT-17 |
| CAS: 324024-00-2 (base), 1322626-23-2 (HCl salt) ; 130777-05-8 (HCl salt) ; |
| Chemical Formula: C19H22ClNO3 |
| Molecular Weight: 347.84 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Paroxetine HCl Hemihydrate EP Impurity A ; Paroxetine HCl Hemihydrate BP Impurity A ; Paroxetine HCl Anhydrous EP Impurity A ; Paroxetine HCl USP Related Compound B ; Desfluoro Paroxetine HCl ; (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine HCl | 324024-00-2 (base), 1322626-23-2 (HCl salt) ; 130777-05-8 (HCl salt) ; is useful as reference Impurity standard. |
